In this week’s episode, Dylan Livingston discusses his work with the Alliance for Longevity Initiatives, focusing on advocating for longevity science in the political arena. He emphasizes the importance of aligning with different political perspectives to promote the field’s growth and the need for more foundational research and FDA support. Dylan also highlights the economic and health benefits of advancing longevity science and calls for public involvement in political advocacy to drive change in health policy and research funding.
What kind of SuperAger are you? Check the SuperAge Quiz and find out! (visit: ageist.com/quiz)
Thanks to our sponsors:
Fatty15 — C15 is the first essential fatty acid to be discovered in 90 years. Fatty15 is on a mission to replenish your C15 levels and restore your long-term health. Get 15% off their 90-day subscription Starter Kit at here with code “AGEIST”.
Sundays — Sundays is healthy, fresh dog food made of human-grade ingredients that is easy to store and serve. No synthetic nutrients or artificial ingredients. Just good quality food for your pup. Get 40% off your first order here with code “AGEIST”.
LMNT Electrolytes — our favorite electrolytes for optimal hydration. Listeners receive a free 8-serving sample pack with their purchase here.
Key Moments
“Alliance for Longevity Initiatives is a 501 (c) (4) non-profit organization focused on representing the longevity biotech industry and general movement on Capitol Hill.”
“This is the next generation of healthcare. And, you know, it’s their job as members of Congress to support and spread awareness around this topic and ultimately try to push more resources towards this effort.”
“You know, this is a major driver of economic growth. I’m sure you have seen the longevity dividend argument which, you know, the latest iteration argues, I think, $37 trillion in GDP gains for one extra healthy year of life expectancy. And even if that’s off by, you know, 90%, $3.7 trillion is still worth pursuing.”
“So really right now, there are two or three major asks that I know will help the longevity industry and thus, I believe, increase healthy lifespan in the US. First and foremost, there needs to be more foundational research for this space in geroscience in general from the federal government. I believe, in 2023, 0.6% of the budget went to geroscience research at the NIH and aging is responsible for 70% of daily deaths.
Second thing we want to get done is we want to help companies better design clinical trials through guidance from the FDA and support through congressional action.
So those are the two big wishlist items. You know, ultimately what we’d like to see in the long term, maybe medium long term, is a longevity initiatives bill.”
The ideas expressed here are solely the opinions of the author and are not researched or verified by AGEIST LLC, or anyone associated with AGEIST LLC. This material should not be construed as medical advice or recommendation, it is for informational use only. We encourage all readers to discuss with your qualified practitioners the relevance of the application of any of these ideas to your life. The recommendations contained herein are not intended to diagnose, treat, cure or prevent any disease. You should always consult your physician or other qualified health provider before starting any new treatment or stopping any treatment that has been prescribed for you by your physician or other qualified health provider. Please call your doctor or 911 immediately if you think you may have a medical or psychiatric emergency.
AUTHOR
We will never sell or give your email to others. Get special info on Diet, Exercise, Sleep and Longevity.
